About Us
Our team
Founder, CEO
Researcher
Researcher
Chief Business Development Officer
AI/ML-engineer
About us
PeptiGen is a biotech startup. We a looking for partners
We have developed an innovative PeptiGen platform that generates unique and patentable peptide structures using artificial intelligence and machine learning methods. PeptiGen has already allowed the development of effective and investment-attractive compounds with antibacterial, antiviral and antitumor activity in vivo.
Scientific publications
Novel Antimicrobial Peptides Designed Using a Recurrent Neural Network Reduce Mortality in Experimental Sepsis
Albert Bolatchiev, Vladimir Baturin, Evgeny Shchetinin, and Elizaveta Bolatchieva
2022. Antibiotics 11, no. 3: 411
Antimicrobial Peptides Epinecidin-1 and Beta-Defesin-3 Are Effective against a Broad Spectrum of Antibiotic-Resistant Bacterial Isolates and Increase Survival Rate in Experimental Sepsis
Albert Bolatchiev
2022. Antibiotics 11, no. 1: 76
Andrographolide and 4-Phenylbutyric Acid Administration Increase the Expression of Antimicrobial Peptides Beta-Defensin-1 and Cathelicidin and Reduce Mortality in Murine Sepsis
Albert Bolatchiev, Vladimir Baturin, and Elizaveta Bolatchieva
2022. Antibiotics 11, no. 11: 1629
Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV–2 Infection
Evgeny Shchetinin, Vladimir Baturin, Eduard Arushanyan, Albert Bolatchiev, and Dmitriy Bobryshev
2022. Antioxidants 11, no. 1: 140
We are in the federal media
In a quiet dip: how fish will help defeat superbugs. Special proteins from the body of marine life will restore the effectiveness of antibiotics that have stopped working
Albert Bolatchiev
Izvestia, January 21, 2022, 00:01
In Russia, with the help of AI, substances with strong antibacterial activity were obtained
Albert Bolatchiev
Тасс, March 29, 2022, 10:46
Russian scientists using AI have obtained substances with strong antibacterial activity
Albert Bolatchiev
Газета.ru, March 29, 2022, 15:19
Artificial intelligence has helped develop new drugs against antibiotic-resistant bacteria
Albert Bolatchiev
RSF, March 29, 2022, 12:00